Jaydira del Rivero, MD | Authors

PARP Inhibitors: The Cornerstone of DNA Repair–Targeted Therapies

April 15, 2017

PARP inhibitors are an active, novel, and exciting class of anticancer agents. They have shown clear patient benefit in gBRCA, HR-deficient, and other ovarian cancers.